Transgenic mice expressing the p75 Cux isoform, which is overexpressed in breast cancers, develop a myeloproliferative disease–like myeloid leukemia (Table 1; Supplementary Figure S1) [96]. Here, CUX1 is linked to myeloproliferative disorder.